Form 4 for ELV Elevance Health
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0001156039-24-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-05 | 2024-11-01 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | F - Tax | $414.01 | -1,649 | 17.2K | -9% | -$682.7K | |
| 2024-11-05 | 2024-11-01 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | A - Grant | $0.00 | +3,799 | 21.0K | +22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | F | D | 1,649 | $414.01 | 17,238 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 2 | Common | Common Stock | 2024-11-01 | A | A | 3,799 | $0.00 | 21,037 | D | — | — | (F2) Represents performance based restricted share units. Restrictions lapse on 11/1/2024. |